摘要:The population pharmacokinetic parameters of aripiprazole in healthy Japanese males were estimated using a nonlinear mixed effects model (NONMEM) program. Pharmacokinetic data for population analysis were obtained from the single-dose (24 subjects), multiple-dose (15 subjects), and itraconazole-coadministration (27 subjects) trials. The time course of plasma aripiprazole concentration following oral administration was well described by a two-compartment model with first-order input. The mean values of the absorption lag time ( ALAG ) and absorption rate constant ( KA ) were estimated to be 0.805 h and 2.65 h−1, respectively. The mean volume of the central ( V 1/ F ) and peripheral ( V 2/ F ) compartment was 3.84 and 1.54 l/kg, respectively, and the mean value of inter-compartment clearance ( Q / F ) was 0.168 l/h/kg. Oral clearance ( CL / F ) was estimated to be 0.0645 l/h/kg in the group with CYP2D6 * 1 /* 1 , * 1 /* 2 and * 2 /* 2 . The decrease in CL / F was estimated to be 0.0135 l/h/kg in the group with CYP2D6 * 1 /* 5 , * 1 /* 10 , * 2 /* 5 , * 2 /* 10 , and * 2 /* 41 , and 0.0293 l/h/kg in the group with CYP2D6 * 5 /* 10 , * 10 /* 10 , and * 41 /* 41 . The plasma concentration of aripiprazole was increased by coadministration of itraconazole, and the decrease in CL / F was estimated to be 0.0181 l/h/kg.